title: Anticoagulation and Renal Insufficiency.
authors.affiliation: 1 Division of Angiology, Lausanne University Hospital, Lausanne.
authors.forename: Angeliki
authors.initials: A
authors.lastname: Koulouri
authors.affiliation: 1 Division of Angiology, Lausanne University Hospital, Lausanne.
authors.forename: Luca
authors.initials: L
authors.lastname: Calanca
authors.affiliation: 1 Division of Angiology, Lausanne University Hospital, Lausanne.
authors.forename: Lucia
authors.initials: L
authors.lastname: Mazzolai
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced; D006801:Humans; D011725:Pyridines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D051437:Renal Insufficiency / Q000097:blood* / Q000145:classification / Q000150:complications*; D000069552:Rivaroxaban / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D020521:Stroke / Q000097:blood* / Q000517:prevention & control*; D013844:Thiazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D013923:Thromboembolism / Q000097:blood* / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors; D014859:Warfarin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D011725:Pyridines; D013844:Thiazoles; D014812:Vitamin K; D014859:Warfarin; D000069552:Rivaroxaban; C552171:edoxaban